Please login to the form below

Not currently logged in
Email:
Password:

COVID treatments

This page shows the latest COVID treatments news and features for those working in and with pharma, biotech and healthcare.

Cambridge University scientists identify 160 new drugs with COVID-19 repurposing potential

Cambridge University scientists identify 160 new drugs with COVID-19 repurposing potential

Scientists at the University of Cambridge have identified 160 new drugs that have potential as repurposed treatments for COVID-19. ... Out of those identified by the Cambridge team, 40 are already in clinical trials as potential treatments for COVID-19

Latest news

More from news
Approximately 0 fully matching, plus 51 partially matching documents found.

Latest Intelligence

  • The lessons learned from COVID-19’s impact on oncology trials The lessons learned from COVID-19’s impact on oncology trials

    How COVID-19’s lasting legacy will reshape clinical cancer research. COVID-19 has dramatically impacted the overall management of clinical trials. ... Even more, sites that conduct clinical trials, like university hospital systems, have understandably

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    Most recently, Japanese firms have led research on plasma-based treatments for COVID-19. ... Not only does this provide a set of challenges for the Japanese government and health system, but for pharmaceutical companies trying to develop new and

  • A cultural shift in clinical research A cultural shift in clinical research

    The impact of the COVID-19 pandemic. For the scientific community, 2020 was a pivotal year. ... But while unprecedented feats were achieved in clinical research for COVID-19 treatments and vaccines, many other projects were halted and patient recruitment

  • Medicinal data – what’s next for IDMP? Medicinal data – what’s next for IDMP?

    The European Medicines Agency's (EMA) headquarters in Amsterdam. The global response to COVID-19 has shone a light on the broader potential for global data standards, including those defined via ... And in 2021, the ability to trace where vaccines and

  • Transforming clinical trial data into a long-term asset Transforming clinical trial data into a long-term asset

    COVID-19 has made 2020 into a pivotal year for the pharmaceutical industry. ... diseases, and prominently in 2020 in the bid to find treatments for COVID-19 in a radically compressed time frame.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...